Defence Therapeutics Inc. (CNSX: DTC)
Health Care · Biotechnology · CA
CA$0.34
-15.00% today · -58.5% 1Y
Defence Therapeutics Inc. (CNSX: DTC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $18.22M and employs 5 people.
Over the last twelve months the share price has lost 58.5%, trading between 0.34 and 0.93.
Tweenvest scores Defence Therapeutics Inc. across four factors: quality 25/100, value 18/100. Its strongest factor is quality.
DTC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $18.22M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- 1.51
- 52-week high
- CA$0.93
- 52-week low
- CA$0.34
- Avg volume (3M)
- —
- Shares outstanding
- 75.79M
- Employees
- 5
- Next earnings
- —
About Defence Therapeutics Inc.
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
- ISIN
- CA24463V1013
- Founded
- 2017
- Listed since
- May 10, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Quoin Pharmaceuticals, Ltd.NasdaqCM: QNRX | $18.74M | $3.90 | -13.33% |
| Estrella Immunopharma, Inc.NasdaqCM: ESLA | $18.70M | $0.43 | +4.88% |
| Akari Therapeutics, PlcNasdaqCM: AKTX | $18.69M | $8.18 | -6.73% |
| Kyntra Bio, Inc.NasdaqGS: KYNB | $18.55M | $4.58 | -12.26% |
| Neuphoria Therapeutics Inc.NasdaqGM: NEUP | $17.86M | $3.30 | -1.79% |
| CCME Global LimitedBSE: 514336 | $17.68M | Rs37.09 | +15.44% |
| Perseus Proteomics Inc.TSE: 4882 | $17.63M | ¥151.00 | -1.31% |
| Marker Therapeutics, Inc.NasdaqCM: MRKR | $17.34M | $1.04 | +7.04% |
Figures last refreshed Oct 18, 2026.